Osteoarthritis

Surgery Versus Watchful Waiting for First Metatarsophalangeal Joint Osteoarthritis : A Randomized Controlled Trial

Ann Intern MedPublished Randomised controlled trial

Primary result · Walking-related pain (NRS 0 to 10), observed meanResult — go to the resultAdjusted mean difference −5.0 points 95% CI −6.1 to −3.9

Authors' conclusion

Among adults aged 40 years or older with painful hallux rigidus, first MTPJ arthrodesis provides a superior and clinically significant reduction in walking-related pain at 12 months compared with watchful waiting.

Study context

Population
Adults aged ≥40 years with radiographically confirmed (Coughlin-Shurnas grade I to III) symptomatic hallux rigidus for over a year and walking pain numerical rating scale (NRS) ≥4; tertiary care hospital orthopedic department, Finland89 completed 12-month follow-up
Participants
90 adults
Comparison
First metatarsophalangeal joint (MTPJ) arthrodesis vs watchful waiting
  • Arthrodesisn = 45
  • Watchful waitingn = 45reference
Primary endpoint
Walking-related pain (NRS 0 to 10); prespecified MCID 1.7 points
Follow-up
12 months
Methodological detailssingle-centre, parallel-group, superiority, 1:1 randomisation, Recruitment November 2021 to June 2024, Mean age 58.1 years
  • Single-centre
  • Parallel-group
  • Superiority
  • 1:1 randomisation
  • Recruitment November 2021 to June 2024
  • Mean age 58.1 years

Primary result

As reported in the abstract

Walking-related pain (NRS 0 to 10), observed mean

Adjusted mean difference

−5.0 points

95% CI −6.1 to −3.9

By group

Arthrodesis

1.3

mean

Watchful waiting

5.7

mean

Arthrodesisvs Watchful waiting
adjusted mean difference −5.0 points (95% CI −6.1 to −3.9)

Original publication

Surgery Versus Watchful Waiting for First Metatarsophalangeal Joint Osteoarthritis : A Randomized Controlled Trial. Ann Intern Med. Published 11 August 2026. doi:10.7326/annals-26-00710

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.